Into the Unknown
On March 17, 2015, I was diagnosed with early-stage breast cancer. Initially it was thought that I would need only a lumpectomy and radiation, but the biopsy changed everything.
The pathology report said that the tumor was HER2-positive and estrogen/progesterone positive. The HER2 protein makes the cancer more aggressive, so I would need, in addition to surgery and radiation, eighteen weeks of standard chemotherapy, a year of two other infused drugs and a hormone-blocking oral drug.
Still, the cancer was stage 1a with a decent prognosis, according to my oncologist, who said, “The good news here is that we have treatments for every part of your cancer. You are lucky.”
